Incannex Healthcare Inc.
IXHLNext catalyst
IHL-42X: dronabinol + acetazolamide
Obstructive Sleep Apnea (OSA)
Get an email about IXHL's next catalysts
Track Incannex Healthcare (IXHL) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
No other upcoming event in our data.
1 upcoming, 1 past
IHL-42X: dronabinol + acetazolamide Phase 2 Est. Readout (DReAMzz)
Estimated primary completion for IHL-42X: dronabinol + acetazolamide trial (NCT07635563) in Obstructive Sleep Apnea (OSA). Topline data typically follows completion by weeks to months.
SourceMarket Overview
Stock performance and key metrics
IHL-42X Low Dose
Obstructive Sleep Apnea
IHL-42X (Optimal Dose)
Obstructive Sleep Apnea
IHL-42X High Dose
Obstructive Sleep Apnea
IHL-42X: dronabinol + acetazolamide
Obstructive Sleep Apnea (OSA)
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
IHL-42X Low Dose | Phase 3 | Obstructive Sleep Apnea | - | - |
IHL-42X (Optimal Dose) | Phase 3 | Obstructive Sleep Apnea | - | - |
IHL-42X High Dose | Phase 3 | Obstructive Sleep Apnea | - | - |
IHL-42X: dronabinol + acetazolamide | Phase 2 | Obstructive Sleep Apnea (OSA) | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Incannex Healthcare Inc.'s drug pipeline?β
CatalystAlert tracks 4 drug candidates in Incannex Healthcare Inc.'s (IXHL) pipeline across Phase 3, Phase 2. Its lead program is IHL-42X (Optimal Dose) (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Incannex Healthcare Inc.'s next FDA catalyst?β
Incannex Healthcare Inc.'s (IXHL) next tracked catalyst is a Phase 2 readout expected April 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track IXHL biotech catalysts?β
Add IXHL to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Incannex Healthcare Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
